Understanding the chemical definition of NAD+ is just the beginning. The more practical question is: what does NAD+ actually do inside living cells? It helps transfer electrons, supports enzymes involved in metabolism and cellular repair, and is constantly recycled and resynthesized as it is used by cells.
In this article, we explain the mechanism of action of NAD+ step by step, including its role as a coenzyme, the relationship between NAD+ and NADH, its involvement in ATP production, its connection to sirtuins, NAD+ biosynthesis, and what can happen when NAD+ availability drops.
1. NAD+ as a Coenzyme – What Does That Actually Mean?
The terms enzyme, cofactor, and coenzyme are sometimes used interchangeably, but they describe different things. Understanding these differences makes it much easier to explain the role of NAD+.
Enzymes are usually proteins, although some RNA molecules can also function as enzymes. Their role is to catalyze, which means to accelerate specific chemical reactions. NAD+ is not an enzyme because it does not catalyze such reactions on its own.
Cofactors are non-protein substances that some enzymes need to function properly. They can be metal ions, such as zinc or magnesium, as well as organic molecules.
Coenzymes are a special type of cofactor. They are organic, carbon-containing helper molecules, often derived from vitamins, that directly participate in enzymatic reactions. They can transfer electrons, chemical groups, or other components from one reaction to another. [1]
NAD+ belongs precisely to this third category.
It is a coenzyme, more specifically one of the most important electron-transferring coenzymes in the body. NAD+ cannot carry out metabolic reactions on its own, but hundreds of enzymes depend on it. The most important of these include enzymes known as dehydrogenases. [1,2]
If the NAD+-dependent dehydrogenase does not have a sufficient amount of available NAD+, its ability to carry out a given reaction may be limited. For this reason, cellular metabolism depends not only on the presence of appropriate enzymes, but also on maintaining adequate availability of the coenzymes needed for their function.
2. How Does NAD+ Transfer Electrons in Redox Reactions?
The best-known function of NAD+ is the transport of electrons during oxidation and reduction reactions, also referred to as redox reactions.
When nutrients such as glucose and fatty acids are broken down, dehydrogenase enzymes often need to take electrons from one molecule and transfer them elsewhere.
NAD+ enables such a transfer.
During the reaction, NAD+ accepts electrons and a hydrogen equivalent at a specific site on its nicotinamide ring. As a result of this reduction reaction, NAD+ is converted into NADH. [1,2]
This relationship can be simplified as follows:
NAD+ → accepts electrons → NADH
NADH can then transfer high-energy electrons to the subsequent reaction. In energy metabolism, one of the most important sites of their utilization is the mitochondrial electron transport chain.
After donating electrons, NADH is oxidized back to NAD+. The recovered NAD+ can then participate in another metabolic reaction.
This creates a continuous cycle in this way:
NAD+ → NADH → NAD+
Instead of being used only once, the molecules repeatedly cycle between the oxidized and reduced forms.
Scientists have developed specialized experimental tools that enable the tracking and modification of these redox processes in specific cellular compartments, including the cytoplasm and mitochondria. These studies have shown that cellular problems can result not only from the absolute amount of NAD+, but also from an imbalance between NAD+ and NADH. [3]
An excessively reduced cellular environment can, for example, contribute to a condition known as reductive stress.
This is one of the reasons why NAD+ is sometimes described as a molecule at a metabolic crossroads. Its redox cycle links nutrient metabolism with mitochondrial energy production, while NAD+ itself also participates in distinct signaling and cellular repair pathways.
3. What Role Does NAD+ Play in ATP Production and Cellular Energy?
The ability of NAD+ to transport electrons is closely linked to ATP production.
ATP, or adenosine triphosphate, is one of the main forms of useful chemical energy in cells.
NAD+ and NADH participate in several interrelated stages of energy metabolism.
Glycolysis
Glycolysis takes place in the cytoplasm and involves breaking down glucose into smaller molecules.
During this process, NAD+ accepts electrons and is converted into NADH. Glycolysis also directly produces a relatively small amount of ATP.
Citric Acid Cycle
Products derived from glucose, fatty acids, and certain amino acids can enter mitochondrial metabolism and be utilized in the citric acid cycle, also known as the Krebs cycle or TCA cycle.
Significant amounts of reduced electron carriers, primarily NADH, are produced in this cycle.
Oxidative Phosphorylation
Electrons transported by NADH can then enter the mitochondrial electron transport chain.
NADH transfers electrons to complex I. As the electrons move through the respiratory chain, the released energy helps pump protons across the inner mitochondrial membrane.
This is how the electrochemical proton gradient is formed.
ATP synthase then uses the energy stored in this gradient to produce ATP. [1,2]
NAD+ is therefore not directly cellular energy. However, its ability to accept and transport electrons helps cells extract useful energy from nutrients and ultimately produce ATP.
Studies utilizing metabolic tracing have also shown that the NAD+ turnover rate varies significantly between tissues. [4]
This has a biological rationale, because individual tissues have different energy requirements and metabolic characteristics. For this reason, a change in NAD+ availability does not necessarily produce identical effects in every organ.
Tissue with a high metabolic rate may react differently than tissue with a significantly lower energy demand.
4. What is the Relationship Between NAD+, Sirtuins, and Aging Research?
NAD+ also plays an important function not directly related to electron transport. It is an essential substrate for enzymes known as sirtuins.
This relationship is one of the main reasons for interest in NAD+ in aging and longevity research.
Seven sirtuins are known in humans, designated as SIRT1 through SIRT7. They are located in various cellular compartments, including the cell nucleus, cytoplasm, and mitochondria.
Sirtuins are involved in processes including:
- regulation of gene expression;
- mitochondrial biology;
- cellular stress response;
- inflammatory signaling;
- DNA repair;
- metabolic regulation. [5]
Many reactions catalyzed by sirtuins involve the removal of acetyl groups from proteins, a process known as deacetylation.
Unlike the role of NAD+ in redox reactions, in which NAD+ and NADH alternate between oxidized and reduced forms, sirtuin reactions consume NAD+ as a substrate.
One of the emerging products is nicotinamide.
This creates a direct biochemical link between cellular NAD+ availability and the activity of NAD+-dependent sirtuins. If the amount of NAD+ is restricted enough, these enzymes may not function at normal efficiency. [5,6]
Individual sirtuins have been studied in various biological contexts.
SIRT1 has generated significant interest due to its involvement in regulating metabolism and the cellular stress response. SIRT2 has been studied in the context of protein acetylation and oxidative stress biology. SIRT3 is located primarily in mitochondria and has been extensively analyzed in studies on mitochondrial metabolism, NAD+, and aging-related processes. [5–7]
The study also included interactions between sirtuin pathways and CD38, an enzyme capable of consuming NAD+.
Animal research has also contributed to interest in this area. In one influential experiment, it was found that the NAD+ precursor, nicotinamide riboside, influenced mitochondrial stress response pathways and improved certain parameters related to stem cells and lifespan in experimental models. [8]
However, this mechanism should not be simplified to the claim that increasing NAD+ automatically increases sirtuin activity and, consequently, extends human lifespan.
The biochemical link between NAD+ and sirtuins is well documented, but lifespan extension in humans through interventions that increase NAD+ levels has not been demonstrated.
5. How Does the Body Produce NAD+?
The body is not dependent on obtaining ready-made NAD+ directly from food. Instead, cells constantly produce and recover it through several biosynthetic pathways.
Two particularly important mechanisms are the salvage pathway and de novo synthesis.
NAD+ Salvage Pathway
The salvage pathway is one of the main ways to maintain NAD+ in many tissues.
When enzymes such as sirtuins and PARPs consume NAD+, one of the breakdown products can be nicotinamide.
Instead of simply removing nicotinamide, cells reuse it.
The NAMPT enzyme, or nicotinamide phosphoribosyltransferase, converts nicotinamide into nicotinamide mononucleotide, commonly referred to as NMN.
NMN is then converted into NAD+ by NMNAT enzymes. [1,2]
This trail can therefore be simplified as follows:
Nicotinamide → NMN → NAD+
This recycling system helps cells constantly replenish NAD+ after it is consumed.
Compounds related to vitamin B3 can also participate in NAD+ biosynthesis via interconnected pathways. These include niacin, nicotinamide, nicotinamide riboside (NR), and NMN.
They enter NAD+ metabolism at different biochemical stages, and not all of them go through the exact same conversion pathway.
De Novo NAD+ Synthesis
The body can also produce NAD+ starting from the amino acid tryptophan.
This process proceeds via the kynurenine pathway.
Tryptophan goes through several metabolic stages that ultimately lead to the formation of quinolinic acid. The QPRT enzyme, or quinolinate phosphoribosyltransferase, then helps direct this pathway toward the production of NAD+. [9]
Under typical conditions in adults, this pathway usually plays a smaller role in the ongoing maintenance of NAD+ than recycling mechanisms.
However, this does not mean that it is biologically insignificant.
Research into genetic defects of enzymes responsible for de novo NAD+ synthesis has linked severe disruptions of this pathway to birth defects in animal models and rare human cases. These findings suggest that adequate de novo NAD+ synthesis may be of particular importance during embryonic development. [9,10]
Thus, the organism maintains NAD+ through interconnected systems rather than a single source.
Cells can both salvage NAD+ breakdown products and synthesize new NAD+ from dietary and metabolic precursors.
6. What Happens When NAD+ Levels Drop?
Because NAD+ is involved in energy metabolism, DNA repair, redox balance, and cell signaling, a decrease in its availability can potentially affect several biological systems simultaneously.
However, the consequences depend on the type of tissue, the degree of deficiency, the NAD+/NADH balance, and the overall physiological state.
Energy Metabolism
Reduced NAD+ availability may disrupt reactions requiring NAD+ as an electron acceptor.
This may ultimately affect mitochondrial metabolism and cellular energy production.
Experimental studies indicate, however, that some tissues have a significant capacity to buffer such changes. Therefore, a measurable drop in NAD+ does not necessarily cause an immediate or proportional deterioration of physiological functions. [4]
Biology of the Cardiovascular System
Cardiovascular studies analyze not only the absolute concentrations of NADH or NAD+, but also the balance between them.
Changes in the NADH-to-NAD+ ratio have been linked to changes in the regulation of mitochondrial proteins in studies of heart failure involving both experimental models and human heart tissue. [11]
These observations indicate a link to cardiovascular metabolism, but they do not prove that NAD+ supplementation is a treatment for heart failure.
Neurological examinations
NAD+ metabolism is also generating significant interest in neuroscience.
Reduced NAD+ availability has been experimentally linked to mitochondrial dysfunction and neuroinflammatory pathways relevant to diseases such as Parkinson's and Alzheimer's.
Early clinical trials have analyzed whether NAD+ precursors can affect NAD+ metabolism in the brain of individuals with Parkinson's disease. In some studies, measurable changes in NAD+-related metabolism in the brain were reported after the administration of precursors. [12,13]
These results remain experimental and should not be interpreted as proof that increasing NAD+ cures Parkinson's disease, Alzheimer's disease, or other neurological disorders.
DNA repair
PARP, or poly(ADP-ribose) polymerases, represent another important group of NAD+-consuming enzymes.
Some PARP enzymes are activated in response to DNA damage and utilize NAD+ in signaling associated with repair processes.
As DNA damage accumulates over a lifetime, increased PARP activity can lead to greater NAD+ depletion.
This creates the possibility of competition between various NAD+-dependent systems. PARPs, sirtuins, CD38, and other NAD+-consuming enzymes ultimately draw from the cellular pool of this molecule. [14]
Researchers therefore suggested that increased NAD+ consumption may contribute to the age-related decline in its availability.
Much of this mechanistic evidence comes from cellular and animal studies. Human studies confirm changes in NAD+ metabolism associated with aging and certain disease states, but their clinical significance and the possibility of reversing these changes remain the subject of ongoing research.
7. What Is the Relationship Between NAD+ and FAD?
NAD+ and FAD are important electron-carrying coenzymes, but they are derived from different vitamin precursors and participate in cellular metabolism in different ways.
FAD stands for flavin adenine dinucleotide.
NAD+ is closely related to vitamin B3 metabolism, whereas FAD is derived from riboflavin, which is vitamin B2.
FAD also accepts electrons during metabolic reactions. Its reduced form is FADH2. [1,2]
Both NADH and FADH2 ultimately supply electrons for mitochondrial energy production processes, but they enter the electron transport chain at different points.
NADH transfers electrons primarily to complex I.
FADH2 delivers electrons through complex II.
Because FADH2 enters the respiratory chain at a later stage, its electrons typically contribute to the pumping of fewer protons, and thus to the production of less ATP than the electrons delivered by NADH to complex I.
NAD+ and FAD are therefore parallel elements of cellular bioenergetics, rather than interchangeable molecules.
Their relationship is also useful in experimental research. Scientists can measure the natural fluorescence associated with reduced NAD(P)H and oxidized FAD to assess the metabolic state of cells and tissues. Such optical methods provide information on changes in redox metabolism without treating either of these coenzymes as a simple, standalone marker. [15]
Mechanism of Action of NAD+ in Brief
| Process | Role of NAD+ |
|---|---|
| Redox reactions | It accepts electrons and transforms into NADH |
| Glycolysis | It supports oxidation reactions during glucose metabolism. |
| Citric acid cycle | It helps collect high-energy electrons in the form of NADH |
| Electron transport chain | NADH delivers electrons to complex I |
| ATP production | It indirectly supports the proton gradient used by ATP synthase |
| Sirtuins | Acts as an essential, consumed substrate |
| PARP | Delivers NAD+ for DNA damage signaling |
| Recovery Trail | NAD+ is regenerated from recovered nicotinamide |
| de novo pathway | NAD+ can be synthesized via tryptophan metabolism |
| Cellular redox balance | The NAD+/NADH ratio helps regulate the metabolic state |
| Relationship with FAD | Both are vitamin-derived electron carriers, but they participate in different pathways |
The most important thing is that NAD+ performs more than one biological function. During metabolism, it acts as a reusable electron carrier, while at the same time being consumed as a substrate by important enzymes responsible for signaling and repair processes.
Limitations of Current Evidence
Much of the detailed knowledge regarding sirtuin activity, the competition between PARP and other NAD+-consuming enzymes, and the balance between the salvage pathway and de novo NAD+ synthesis comes from studies on cell cultures and animal models. The extent to which individual mechanisms translate to various human tissues and disease states is still being investigated. [5,6,9]
The relationship between NAD+ decline and cardiovascular or neurological diseases is also complex. Mechanistic links do not imply that low NAD+ is the primary cause of disease, nor that therapeutically increasing NAD+ will reverse it. Larger, controlled human trials are needed to confirm such effects. [11–13]
Experimental results also show that even a significant reduction in NAD+ does not always lead to as large a decline in function as might be expected. This suggests that tissues may possess a metabolic reserve, and NAD+ concentration alone does not fully determine their function. [4]
Finally, evidence pointing to the importance of de novo NAD+ synthesis during embryonic development comes largely from genetic studies and animal models. Corresponding human data are limited primarily to rare congenital disorders involving the respective enzymes. [9,10]
Disclaimer
This article is for educational, scientific, and informational purposes only. It does not constitute medical advice, a diagnosis, treatment guidelines, dosage instructions, or a recommendation regarding the use of NAD+, NR, NMN, niacin, nicotinamide, or any other NAD+-related compounds.
Research on NAD+ encompasses both well-understood biochemical mechanisms and the results of cellular, animal, and human studies, which vary in the level and quality of evidence. Changes in NAD+ metabolism, sirtuin activity, mitochondrial function, or other cellular pathways should not be interpreted as proof that increasing NAD+ levels prevents, treats, or reverses aging, cardiovascular disease, neurological disorders, metabolic diseases, or any other conditions.
Interventions aimed at increasing NAD+ levels and their long-term clinical effects remain the subject of active research. The results of mechanistic studies and an increase in measured NAD+ levels do not necessarily translate into significant health benefits in humans.
References
- Yoshino, J., Baur, J. A., & Imai, S. (2018). NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metabolism, 27(3), 513–528. https://doi.org/10.1016/j.cmet.2017.11.002
- Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141. https://doi.org/10.1038/s41580-020-00313-x
- Titov, D. V., et al. (2016). Complementation of mitochondrial electron transport chain dysfunction by manipulation of the NAD+/NADH ratio. Science, 352(6282), 231–235. https://pubmed.ncbi.nlm.nih.gov/27124460/
- Liu, L., et al. (2018). Quantitative analysis of NAD synthesis and breakdown fluxes. Cell Metabolism, 27(5), 1067–1080. https://pubmed.ncbi.nlm.nih.gov/29685734/
- Lemos, V., et al. (2017). The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes. Human Molecular Genetics, 26(21), 4105–4117. https://pubmed.ncbi.nlm.nih.gov/28973648/
- Liu, G., et al. (2016). Loss of NAD-dependent protein deacetylase sirtuin-2 alters mitochondrial protein acetylation and dysregulates mitophagy. Antioxidants & Redox Signaling, 26(15), 849–863. https://pubmed.ncbi.nlm.nih.gov/27460777/
- Camacho-Pereira, J., et al. (2016). CD38 dictates age-related NAD decline and mitochondrial dysfunction through a SIRT3-dependent mechanism. Cell Metabolism, 23(6), 1127–1139. https://pubmed.ncbi.nlm.nih.gov/27304511/
- Zhang, H., et al. (2016). NAD+ repletion improves mitochondrial and stem cell function and enhances lifespan in mice. Science, 352(6292), 1436–1443. https://pubmed.ncbi.nlm.nih.gov/27127236/
- Szot, J. O., et al. (2020). Bi-allelic mutations in NADSYN1 cause multiple organ defects and expand the genotypic spectrum of congenital NAD deficiency disorders. American Journal of Human Genetics, 106(1), 129–136. https://pubmed.ncbi.nlm.nih.gov/31883644/
- Cuny, H., et al. (2020). Gene-environment interactions and NAD+ deficiency cause congenital malformations and miscarriage in mice. Proceedings of the National Academy of Sciences. https://pubmed.ncbi.nlm.nih.gov/32015132/
- Lee, C. F., et al. (2016). Normalization of NAD+ redox balance as a therapy for heart failure. Circulation, 134(12), 883–894. https://pubmed.ncbi.nlm.nih.gov/27489254/
- Brakedal, B., et al. (2022). The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease. Cell Metabolism, 34(3), 396–407. https://pubmed.ncbi.nlm.nih.gov/35235774/
- Hou, Y., et al. (2021). NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer’s disease via cGAS-STING. Proceedings of the National Academy of Sciences, 118(37). https://pubmed.ncbi.nlm.nih.gov/34497121/
- Koczor, C. A., et al. (2021). Temporal dynamics of base excision/single-strand break repair protein complex assembly/disassembly are modulated by the PARP/NAD+/SIRT6 axis. Cell Reports, 37(5), 109917. https://pubmed.ncbi.nlm.nih.gov/34731617/
- Wallrabe, H., Svindrych, Z., Alam, S. R., et al. (2018). Segmented cell analyses to measure redox states of autofluorescent NAD(P)H, FAD & Trp in cancer cells by FLIM. Scientific Reports, 8, 79. https://pubmed.ncbi.nlm.nih.gov/29311591/